Evidence map›Paper›PMID 32350470›Full record

ArticleNature2020

Nucleosome-bound SOX2 and SOX11 structures elucidate pioneer factor function.

Svetlana O Dodonova, Fangjie Zhu, Christian Dienemann, Jussi Taipale, Patrick Cramer

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 287 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genetic architecture of craniofacial morphogenesis: roles ofFrontiers in cell and developmental biology · 2026
    Review
  20. Article

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Svetlana O DodonovaDepartment of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.ORCID http://orcid.org/0000-0002-5002-8138
Fangjie ZhuDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-0143-5765
Christian DienemannDepartment of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Jussi TaipaleDepartment of Biochemistry, University of Cambridge, Cambridge, UK.
Patrick CramerDepartment of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. patrick.cramer@mpibpc.mpg.de.ORCID http://orcid.org/0000-0001-5454-7755
Max Planck Institute for Biophysical Chemistry · DEUniversity of Cambridge · GB

Funding

Cancer Research UK 28801Medical Research Council MR/V000500/1
6 · The paper itself

Abstract

'Pioneer' transcription factors are required for stem-cell pluripotency, cell differentiation and cell reprogramming

Indexed as

Chromatin Assembly and DisassemblyCryoelectron MicroscopyBase SequenceDNA, SuperhelicalHistonesHumansLysineModels, BiologicalModels, MolecularMultiprotein ComplexesNucleosomesSOXB1 Transcription FactorsSOXC Transcription FactorsDNA, SuperhelicalHistonesLysineMultiprotein ComplexesNucleosomesSOX11 protein, humanSOX2 protein, humanSOXB1 Transcription FactorsSOXC Transcription Factors

Identifiers

PMID32350470
OpenAlexW3018363245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.